Patients were randomized to receive either low-molecular-weight heparin (enoxaparin) throughout the index hospitalization (1 week) (n = 10,256) or weight-based UFH for at least 48 hours (n = 10,223).

As with the brand-name formulation, generic enoxaparin injection will be available in prefilled syringes containing 30 mg/0.3 mL, 40 mg/0.4 mL, 60 mg/0.6 mL, 80 mg/0.8 mL, 100 mg/mL, 120 mg/0.8 mL ...